Vepdegestrant, a Proteolysis Targeting Chimera (PROTAC) Estrogen Receptor (ER) Degrader, in ER Plus /human Epidermal Growth Factor Receptor 2 (HER2)- Advanced Breast Cancer: Update of Dose Escalation Results from a Phase I/II Trial
ANNALS OF ONCOLOGY(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要